Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
E.P.T.Q Dermal Filler Line
EPTQ Lidocaine 1.1ml — JETEMA’s CE-certified Korean HA dermal filler with ZEEP purification. 3 depth-tuned SKUs (S100 / S300 / S500), 24 mg/mL HA + 0.3% premixed lidocaine, up to 12 months. For licensed healthcare professionals only.
$30.00
Quantity discounts
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 3% | $29.10 |
| 10-19 | 5% | $28.50 |
| 20-Unlimited | 8% | $27.60 |
EPTQ Lidocaine 1.1ml — Korean HA Dermal Filler with ZEEP Purification and 3 Depth-Tuned SKUs
24 mg/mL
Cross-linked HA
0.3% Lido
Premixed
1.1 mL
Syringe + 27G
CE 2292
KFDA · Korea
Product Overview
EPTQ (epitique) is JETEMA’s CE-certified HA dermal filler — three lidocaine-premixed SKUs spanning superficial dermis to deep subcutaneous correction. JETEMA’s ZEEP process targets <0.1 EU/mL endotoxin and ~1% modification rate, reducing residual BDDE and post-procedural inflammation risk.
Variants
All three SKUs: 24 mg/mL HA + 0.3% lidocaine, 1.1 mL syringe. Differ by injection depth.
| SKU | Injection Depth | Primary Use |
|---|---|---|
| EPTQ S100 Lidocaine | Superficial-mid dermis | Fine lines, periorbital, neck |
| EPTQ S300 Lidocaine | Mid-deep dermis | NLF, marionettes, lip body |
| EPTQ S500 Lidocaine | Subcutaneous | Cheeks, chin, jawline, nose |
EPTQ S100 Lidocaine — Fine Lines & Periorbital
EPTQ S100 Lidocaine is the lightest cross-linked HA in the EPTQ line, formulated for superficial-to-mid dermal placement. Best for fine lines, periorbital wrinkles, and neck rejuvenation.
EPTQ S300 Lidocaine — NLF, Marionettes & Lip Body
EPTQ S300 Lidocaine offers medium cross-linking density for mid-to-deep dermal correction. Designed for nasolabial folds, marionette lines, and lip body augmentation.
EPTQ S500 Lidocaine — Cheeks, Chin & Jawline
EPTQ S500 Lidocaine is the firmest variant for subcutaneous and supraperiosteal volumization. Indicated for cheek augmentation, chin projection, jawline contouring, and nose dorsum support.
Specifications
| Manufacturer | JETEMA Co., Ltd. · Seoul, South Korea |
| Composition | HA 24 mg/mL · 0.3% lidocaine · phosphate buffer pH 7 |
| Cross-linker | BDDE · ZEEP process · MoD ~1% |
| Packaging | 1 × 1.1 mL pre-filled syringe + 2 × 27G needles |
| Duration | Up to 12 months |
| Storage | 2–25 °C · do not freeze · protect from light |
| Shelf Life | 24 months unopened |
| Regulatory | CE 2292 · KFDA · ANVISA · ISO 13485 |
| Intended Use | Licensed medical professionals only |
FAQ
What’s the difference between S100, S300, and S500?+
All share the same 24 mg/mL HA backbone but differ in cross-linking density. S100 (low) for superficial-to-mid dermis; S300 (medium) for nasolabial folds, marionettes, and lip body; S500 (high) for subcutaneous volumization — cheeks, chin, jawline.
How long do EPTQ results last?+
JETEMA clinical data supports up to 12 months. Duration varies by variant, injection depth, treated area, and patient metabolism. Deep volumetric placements typically outlast superficial dermal placements.
Can EPTQ variants be combined in one session?+
Yes — a common full-face protocol uses S500 for midface, S300 for nasolabial folds and lips, and S100 for fine lines. All variants share the same HA base and manufacturing process.
Is EPTQ FDA-approved?+
EPTQ holds CE 2292, KFDA, ANVISA, and ISO 13485. Not currently FDA-approved in the United States. Buyers should verify import and use status in their own jurisdiction.
What is ZEEP technology?+
ZEEP (Zero Endotoxin and BDDE Entire Process) is JETEMA’s proprietary purification and cross-linking workflow. EPTQ achieves endotoxin below 0.1 EU/mL and modification degree near 1%, reducing residual BDDE and post-procedural irritation risk.
Who is qualified to inject EPTQ?+
Licensed physicians, dermatologists, plastic surgeons, and trained aesthetic practitioners only. Buyers self-certify professional status at checkout.
Safety Information
Prescription device for licensed practitioners only. Contraindicated in active local infection, known hypersensitivity, pregnancy/breastfeeding, and anticoagulant therapy. Standard HA filler vascular complication protocols apply — aspirate before injection, have hyaluronidase on hand.
→ Full Dermal Filler Safety Information
Manufactured by JETEMA Co., Ltd. under CE 2292 and KFDA approvals. Not FDA-approved. Informational only — not medical advice.
| ProType |
S100, S300, S500 |
|---|
Related Products
Juvederm Ultra 2 (2 X 0.55ml)
Juvederm Ultra 2 is an hyaluronic acid filler (24 mg/ml HA + 0.3% lidocaine) specifically engineered for correcting moderate nasolabial folds, perioral lines, and lip augmentation. Clinical trials demonstrate 92% patient satisfaction at 4-week follow-up, with 68% reduction in injection discomfort versus non-anesthetic fillers. Utilizing VYCROSS™ technology, it provides 9-12 month duration through optimized cross-linking density (20% high/80% low molecular weight HA chains) while maintaining 94% natural tissue mobility post-treatment.
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
1 review for E.P.T.Q Dermal Filler Line
Clear filters